Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: a subgroup analysis of the PROLOGUE study

• Prif Awduron: Yipin Zhao (Awdur), Huawei Wang (Awdur), Dazhi Ke (Awdur), Wei Deng (Awdur), Yingying Ji (Awdur), Jiaojiao Yang (Awdur), Zebin Lin (Awdur), Guoxing Li (Awdur), Li Xiao (Awdur), Jianmin Tang (Awdur), Qingwei Chen (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: SAGE Publishing, 2021-06-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background and Aims: Studies have shown that dipeptidyl peptidase-4 (DDP-4) inhibitors have anti-atherosclerotic effects. However, in the PROLOGUE study, sitagliptin failed to slow the progression of carotid intima-media thickness (CIMT) relative to conventional therapy. We conducted a post hoc anal...